Abilify Maintena 400 Mg Aripiprazole Extended-Release Injectable Suspension
Abilify Maintena 400 Mg Aripiprazole Extended-Release Injectable Suspension
Abilify Maintena is an extended-release injectable suspension designed for the treatment of schizophrenia and bipolar I disorder. This once-monthly injection provides a consistent delivery of aripiprazole, helping to stabilize symptoms effectively.
Key Features- Extended-release formulation for monthly administration
- Used in the treatment of schizophrenia and bipolar I disorder
- Helps maintain stable symptoms
- Dosage 400 mg
- Form Injectable suspension
- Administration Intramuscular
Ideal for patients requiring long-term management of schizophrenia or bipolar I disorder.
Typical User/Industry ProfileHealthcare professionals administering treatment for mental health disorders.
About the BrandAbilify Maintena is a trusted name in the field of mental health treatment, known for its innovative approach to long-term symptom management.
Original: $458.58
-65%$458.58
$160.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Abilify Maintena 400 Mg Aripiprazole Extended-Release Injectable Suspension
Abilify Maintena is an extended-release injectable suspension designed for the treatment of schizophrenia and bipolar I disorder. This once-monthly injection provides a consistent delivery of aripiprazole, helping to stabilize symptoms effectively.
Key Features- Extended-release formulation for monthly administration
- Used in the treatment of schizophrenia and bipolar I disorder
- Helps maintain stable symptoms
- Dosage 400 mg
- Form Injectable suspension
- Administration Intramuscular
Ideal for patients requiring long-term management of schizophrenia or bipolar I disorder.
Typical User/Industry ProfileHealthcare professionals administering treatment for mental health disorders.
About the BrandAbilify Maintena is a trusted name in the field of mental health treatment, known for its innovative approach to long-term symptom management.
